These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 600900)

  • 21. Clomipramine: plasma levels, side effects and outcome in obsessive-compulsive neurosis.
    Stern RS; Marks IM; Wright J; Luscombe DK
    Postgrad Med J; 1980; 56 Suppl 1():134-9. PubMed ID: 7393824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma levels and clinical improvement--a comparative study of clomipramine and amitriptyline in depression.
    Moyes IC; Ray RL; Moyes RB
    Postgrad Med J; 1980; 56 Suppl 1():127-9. PubMed ID: 7393822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clomipramine and desmethylclomipramine: relationship between plasma levels and clinical effect (author's transl)].
    Vandel B; Vandel S; Jounet JM; Allers G; Volmat R
    Encephale; 1981; 7(5):601-8. PubMed ID: 7327152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical experience with maprotilin and maprotilin/clomipramine infusions in resistant depression.
    Zapletálek M; Zbytovský J; Kudrnová K
    Act Nerv Super (Praha); 1982 May; 24(2):73-6. PubMed ID: 7102227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relationship of plasma clomipramine and N-desmethylclomipramine to response in obsessive-compulsive disorder.
    Mavissakalian M; Jones B; Olson S; Perel JM
    Psychopharmacol Bull; 1990; 26(1):119-22. PubMed ID: 2371366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Plasma levels of desmethylclomipramine and clomipramine at steady-state in the morning. Correlative analysis and prediction of theoretical blood clomipramine].
    Champiat JC; Aymard N; des Lauriers A
    Encephale; 1983; 9(1):23-36. PubMed ID: 6872932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relating plasma levels of clomipramine and clinical response.
    Seldrup J
    J Int Med Res; 1980; 8 Suppl 3():96-110. PubMed ID: 7202825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of clomipramine in phobic patients. Preliminary research report.
    Carey MS; Hawkinson R; Kornhaber A; Wellish CS
    Curr Ther Res Clin Exp; 1975 Jan; 17(1):107-10. PubMed ID: 806423
    [No Abstract]   [Full Text] [Related]  

  • 29. Proceedings: Systematic clinical studies with clomipramine in depressed psychiatric patients--IV. A summary report.
    Lehmann HE; Ban TA; Pecknold JC
    Psychopharmacol Bull; 1976 Jan; 12(1):27-9. PubMed ID: 1108080
    [No Abstract]   [Full Text] [Related]  

  • 30. Proceedings: Systematic clinical studies with clomipramine in depressed psychiatric patients--I. Report on an uncontrolled clinical trial.
    Campbell P; Ananth JV; Gomez L
    Psychopharmacol Bull; 1976 Jan; 12(1):23-4. PubMed ID: 1108077
    [No Abstract]   [Full Text] [Related]  

  • 31. The demethylation of imipramine and clomipramine as apparent from their plasma kinetics.
    Nagy A; Johansson R
    Psychopharmacology (Berl); 1977 Oct; 54(2):125-31. PubMed ID: 412206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proceedings: Systematic clinical studies with clomipramine in depressed psychiatric patients--III. Standard-controlled clinical trial.
    Pecknold JC; Gratton L; Ban TA; Klingner A
    Psychopharmacol Bull; 1976 Jan; 12(1):26-7. PubMed ID: 1108079
    [No Abstract]   [Full Text] [Related]  

  • 33. Proceedings: Systematic clinical studies with clomipramine in depressed psychiatric patients--II. Report on a placebo-controlled clinical trial.
    Pecknold JC; Amin MM; Ban TA; Orbach L
    Psychopharmacol Bull; 1976 Jan; 12(1):24-5. PubMed ID: 1108078
    [No Abstract]   [Full Text] [Related]  

  • 34. Double-blind trial with oral versus intravenous clomipramine in primary depression.
    Faravelli C; Broadhurst AD; Ambonetti A; Ballerini A; De Biase L; La Malfa G; Das M
    Biol Psychiatry; 1983 Jun; 18(6):695-706. PubMed ID: 6871303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravenous pulse loading of clomipramine in adolescents with depression.
    Sallee FR; Pollock BG; Perel JM; Ryan ND; Stiller RL
    Psychopharmacol Bull; 1989; 25(1):114-8. PubMed ID: 2772110
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clomipramine and demethylclomipramine. Correlation of plasma levels and efficacy in 24 depressive patients].
    Pascalis G; Wargny E; Lamiable D; Havet JM
    Encephale; 1987; 13(4):239-44. PubMed ID: 3665819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clomipramine: plasma levels and clinical effects.
    Reisby N; Gram LF; Bech P; Sihm F; Krautwald O; Elley J; Ortmann J; Christiansen J
    Commun Psychopharmacol; 1979; 3(5):341-51. PubMed ID: 548213
    [No Abstract]   [Full Text] [Related]  

  • 38. Relationship between the plasma concentration of clomipramine and desmethylclomipramine in depressive patients and the clinical response.
    Vandel B; Vandel S; Jounet JM; Allers G; Volmat R
    Eur J Clin Pharmacol; 1982; 22(1):15-20. PubMed ID: 7094971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mass fragmentographic analysis of clomipramine and its mono-demethylated metabolite in human plasma.
    Alfredsson G; Wiesel FA; Fyro B; Sedvall G
    Psychopharmacology (Berl); 1977 Mar; 52(1):25-30. PubMed ID: 403553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single oral dose pharmacokinetics of clomipramine in depressed patients.
    Dawling S; Braithwaite RA; McAuley R; Montgomery SA
    Postgrad Med J; 1980; 56 Suppl 1():115-6. PubMed ID: 7393820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.